Yacine Merrouche

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1997 · 429 citations

Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer

Érick Gamelin, R. Delva, J H Jacob et al. · Journal of Clinical Oncology · 2008 · 330 citations

Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen

Thierry André, M.A. Bensmaïne, Christophe Louvet et al. · Journal of Clinical Oncology · 1999 · 280 citations

Development and Validation of a Prognostic Model to Predict the Length of Survival in Patients With Carcinomas of an Unknown Primary Site

Stéphane Culine, Andrew Kramar, Mahasti Saghatchian et al. · Journal of Clinical Oncology · 2002 · 205 citations

Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)

Stéphane Culine, Alain Lortholary, Jean‐Jacques Voigt et al. · Journal of Clinical Oncology · 2003 · 151 citations